Nasdaq24d
LAVA Therapeutics Doses First Patient in Phase 1 Study of Bispecific Gammabody® LAVA-1266 for CD123-Expressing Blood Cancers
First patient dosed in the Phase 1, first-in-human study of LAVA-1266, marking a significant milestone for the company. LAVA-1266 has demonstrated a strong preclinical safety and efficacy profile ...
University of Arkansas24d
U of A Community Mourns Loss of Adrienne Gaines
It is with great sadness that the College of Engineering announces the passing of Adrienne Lynnette Gaines, a beloved wife, mother, daughter, sister, aunt, niece, cousin, colleague, boss and friend.